Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
4.550
-0.100 (-2.15%)
At close: Dec 5, 2025, 4:00 PM EST
4.600
+0.050 (1.10%)
After-hours: Dec 5, 2025, 7:25 PM EST
Annovis Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 5.26 | 6.7 | 6.24 | 9 | 6.06 | 3.59 | |
| Research & Development | 21.46 | 20 | 38.79 | 16.52 | 8.48 | 3.05 | |
| Operating Expenses | 26.72 | 26.69 | 45.04 | 25.51 | 14.54 | 6.64 | |
| Operating Income | -26.72 | -26.69 | -45.04 | -25.51 | -14.54 | -6.64 | |
| Interest & Investment Income | 0.66 | 0.33 | 0.67 | 0.18 | 0.01 | 0.05 | |
| Other Non Operating Income (Expenses) | 1.18 | 1.77 | -11.84 | - | 0.04 | 1.13 | |
| Pretax Income | -24.88 | -24.59 | -56.2 | -25.33 | -14.49 | -5.46 | |
| Net Income | -24.88 | -24.59 | -56.2 | -25.33 | -14.49 | -5.46 | |
| Net Income to Common | -24.88 | -24.59 | -56.2 | -25.33 | -14.49 | -5.46 | |
| Shares Outstanding (Basic) | 18 | 12 | 9 | 8 | 8 | 6 | |
| Shares Outstanding (Diluted) | 18 | 12 | 9 | 8 | 8 | 6 | |
| Shares Change (YoY) | 61.36% | 35.60% | 10.55% | 7.03% | 20.88% | 2132.36% | |
| EPS (Basic) | -1.40 | -2.02 | -6.23 | -3.10 | -1.90 | -0.87 | |
| EPS (Diluted) | -1.44 | -2.31 | -6.23 | -3.10 | -1.90 | -0.87 | |
| EBIT | -26.72 | -26.69 | -45.04 | -25.51 | -14.54 | -6.64 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.